These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36444198)

  • 1. c(RGDyK)-Decorated Pluronic Micelles for Enhanced Doxorubicin and Paclitaxel Delivery to Brain Glioma [Retraction].
    Int J Nanomedicine; 2022; 17():5603-5604. PubMed ID: 36444198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma.
    Huang Y; Liu W; Gao F; Fang X; Chen Y
    Int J Nanomedicine; 2016; 11():1629-41. PubMed ID: 27143884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) Peptide.
    Chen Y; Zhang W; Huang Y; Gao F; Fang X
    PLoS One; 2016; 11(3):e0149952. PubMed ID: 26930626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Therapeutic Effect of Methotrexate-Conjugated Pluronic-Based Polymeric Micelles on the Folate Receptor-Rich Tumors Treatment [Retraction].
    Int J Nanomedicine; 2022; 17():5601-5602. PubMed ID: 36444197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Fang X
    Int J Nanomedicine; 2015; 10():4863-81. PubMed ID: 26257522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Design of Multifunctional Micelles Against Doxorubicin-Sensitive and Doxorubicin-Resistant MCF-7 Human Breast Cancer Cells [Retraction].
    Int J Nanomedicine; 2022; 17():3055-3056. PubMed ID: 35836837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
    Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel.
    Ma Y; Fan X; Li L
    Carbohydr Polym; 2016 Feb; 137():19-29. PubMed ID: 26686101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluronic-poly (acrylic acid)-cysteine/Pluronic L121 mixed micelles improve the oral bioavailability of paclitaxel.
    Zhao Y; Li Y; Ge J; Li N; Li LB
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1483-93. PubMed ID: 23971495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Fluorescence Study of the Interaction of Anticancer Drug Molecule Doxorubicin Hydrochloride in Pluronic P123 and F127 Micelles.
    Behera SK; Mohanty ME; Mohapatra M
    J Fluoresc; 2021 Jan; 31(1):17-27. PubMed ID: 33037527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid coated Pluronic F127/Pluronic P123 mixed micelle for targeted delivery of Paclitaxel and Curcumin.
    Anirudhan TS; Varghese S; Manjusha V
    Int J Biol Macromol; 2021 Dec; 192():950-957. PubMed ID: 34662655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation.
    Dahmani FZ; Yang H; Zhou J; Yao J; Zhang T; Zhang Q
    Eur J Pharm Sci; 2012 Aug; 47(1):179-89. PubMed ID: 22683386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro Evaluation of Doxorubicin-Loaded Fe
    Int J Nanomedicine; 2020; 15():5573-5574. PubMed ID: 32848388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized Pluronic-b-poly(ε-caprolactone) based nanocarriers of paclitaxel: solubilization, antiproliferative efficacy and in vivo pharmaceutic kinetics.
    Du Z; Zhang Y; Xu H; Lang M
    J Mater Chem B; 2015 May; 3(18):3685-3694. PubMed ID: 32262843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
    Wei Z; Yuan S; Hao J; Fang X
    Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of pluronic micelle-encapsulated doxorubicin and formaldehyde-releasing prodrugs for localized anticancer chemotherapy.
    Ugarenko M; Chan CK; Nudelman A; Rephaeli A; Cutts SM; Phillips DR
    Oncol Res; 2009; 17(7):283-99. PubMed ID: 19408574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
    Wang Y; Yu L; Han L; Sha X; Fang X
    Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction].
    Int J Nanomedicine; 2022; 17():2319-2320. PubMed ID: 35637839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.